Uniphos Enterprises Limited
Uniphos Enterprises Limited (UNIENTER) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Trading - Chemicals
uelonline.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 73 Cr | 6 Cr | 0 Cr | 0 Cr |
| Operating expenses (approx.) | 74 Cr | 7 Cr | 1 Cr | 0.97 Cr |
| EBITDA | -2 Cr | -0.83 Cr | -1 Cr | -0.97 Cr |
| OPM % | -2.2% | -14.2% | — | — |
| Other income | 0.21 Cr | 0.27 Cr | 24 Cr | 0.13 Cr |
| Interest | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Depreciation | 0.19 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr |
| Profit before tax | -2 Cr | -0.74 Cr | 23 Cr | -1 Cr |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | -2 Cr | -0.74 Cr | 23 Cr | -1 Cr |
| EPS (₹) | ₹-0.23 | ₹-0.11 | ₹3.33 | ₹-0.15 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 112 Cr | Sign in for TTM |
| Operating expenses (approx.) | 115 Cr | Sign in for TTM |
| EBITDA | -4 Cr | Sign in for TTM |
| OPM % | -3.4% | Sign in for TTM |
| Other income | 6 Cr | Sign in for TTM |
| Interest | 1 Cr | Sign in for TTM |
| Depreciation | 0.75 Cr | Sign in for TTM |
| Profit before tax | 0.23 Cr | Sign in for TTM |
| Tax % | -22.7% | Sign in for TTM |
| Net profit | 0.28 Cr | Sign in for TTM |
| EPS (₹) | ₹0.04 | Sign in for TTM |
| Dividend payout % | 14244.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 14 Cr |
| Reserves | 2,728 Cr |
| Borrowings | — |
| Other liabilities | 100 Cr |
| Total liabilities | 2,842 Cr |
| Fixed assets (net) | 0 Cr |
| CWIP | 0 Cr |
| Investments | 2,798 Cr |
| Cash & bank | 12 Cr |
| Other assets | 32 Cr |
| Total assets | 2,842 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -3 Cr |
| Cash from investing | 53 Cr |
| Cash from financing | -41 Cr |
| Net cash flow | 9 Cr |
| Free cash flow (OCF − Capex) | -3 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 0.1% |
| ROE % | 0.0% |
| Debtor days | 0 |
| Inventory days | 0 |
| Days payable | 2 |
| Cash conversion cycle | -2 |
| Debt / equity | 0.00 |
| Current ratio | 8.83 |
| Net debt / EBITDA | — |
Compare with peers
Loading peers…